The Health Effects of Cannabis and Cannabinoids The Current State of Evidence and Recommendations for Research (2017) / Chapter Skim
Currently Skimming:
16 Recommendations to Support and Improve the Cannabis Research Agenda
16 Recommendations to Support and Improve the Cannabis Research Agenda
Pages 395-402
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 395... ...
The aspirational goal and organizing principle of this agenda should be to maximize the population-health impact of cannabis research. Achieving this objective will require coordination and collaboration among researchers and research groups; support from stakeholders at the local, state, and national levels; and the concurrent pursuit of several distinct research streams, including clinical and observational research and research in the areas of health policy, health economics, public health, and public safety.
|
From page 396... ...
, public agencies,1 philanthropic and professional organizations, private companies, and clinical and public health research groups should provide funding and support for a national cannabis research agenda that addresses key gaps in the evidence base. Prioritized research streams and objectives should include, but need not be limited to: Clinical and Observational Research • Examine the health effects of cannabis use in at-risk or under researched populations, such as children and youths (often described as less than 18 years of age)
|
From page 397... ...
• Characterize public safety concerns related to recreational can nabis use and evaluate existing quality assurance, safety, and packaging standards for recreational cannabis products. IMPROVE RESEARCH QUALITY In order to effectively guide health care decisions and inform public policy, the proposed cannabis research agenda must produce conclusive, actionable evidence.
|
From page 398... ...
, and Cochrane guidelines for systematic reviews. Adequately addressing these topics will require input from numerous stakeholders, including clinical and public health cannabis researchers; research methodologists; representatives from working groups that have developed research reporting guidelines; organizations engaged in standards development; representatives from scientific publications; and representatives from government agencies directly or indirectly involved in the research process, including the U.S.
|
From page 399... ...
State public health departments can collaborate with Association of Public Health Laboratories to use existing public health laboratories to provide diagnostic tools and other laboratory resources to meet the needs of clinical and public health professionals engaged in cannabis research. Because of differences in cannabis product type, availability, access, and regulation, such surveillance efforts need to be state based, for the time being.
|
From page 400... ...
, the Cen ters for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, the Association of State and Territorial Health Officials, the National Association of County and City Health Officials, the Association of Public Health Laboratories, and state and local public health depart ments should fund and support improvements to federal pub lic health surveillance systems and state-based public health surveillance efforts. Potential efforts should include, but need not be limited to: • The development of question banks on the harmful and beneficial health effects of therapeutic and recreational cannabis use and their incorporation into major public health surveys, including the National Health and Nutrition Examination Survey, National Health Interview Survey, Behavioral Risk Factor Surveillance System, National Survey on Drug Use and Health, Youth Risk Behavior Surveillance System, National Vital Statistics System, Medical Expenditure Panel Survey, and National Survey of Fam ily Growth.
|
From page 401... ...
The evidence discussed in this report suggests that cannabis has both therapeutic value and public health risks. The public health case for pursuing cannabis research, which is premised on this potential for both harm and benefit, is sharpened by the increased prevalence of cannabis use in states where medical and recreational cannabis has been legalized.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.